Shenzhen Bioeasy Biotechnology Balance Sheet Health
Financial Health criteria checks 3/6
Shenzhen Bioeasy Biotechnology has a total shareholder equity of CN¥843.4M and total debt of CN¥411.7M, which brings its debt-to-equity ratio to 48.8%. Its total assets and total liabilities are CN¥1.4B and CN¥552.7M respectively.
Key information
48.8%
Debt to equity ratio
CN¥411.71m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥620.67m |
| Equity | CN¥843.44m |
| Total liabilities | CN¥552.70m |
| Total assets | CN¥1.40b |
Financial Position Analysis
Short Term Liabilities: 300942's short term assets (CN¥749.7M) exceed its short term liabilities (CN¥130.9M).
Long Term Liabilities: 300942's short term assets (CN¥749.7M) exceed its long term liabilities (CN¥421.8M).
Debt to Equity History and Analysis
Debt Level: 300942 has more cash than its total debt.
Reducing Debt: 300942's debt to equity ratio has increased from 0% to 48.8% over the past 5 years.
Debt Coverage: 300942's debt is not well covered by operating cash flow (6.4%).
Interest Coverage: Insufficient data to determine if 300942's interest payments on its debt are well covered by EBIT.